Objective-Trivalent chromium (Cr 3ϩ ) is an essential micronutrient. Findings since the 1950s suggest that Cr 3ϩ might benefit cholesterol homeostasis. Here we present mechanistic evidence in support of this role of Cr 3ϩ . Methods and Results-High-density lipoprotein cholesterol generation in 3T3-L1 adipocytes, which are rendered ineffective by the hyperinsulinemia that is known to accompany disorders of lipid metabolism, was corrected by Cr 3ϩ
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. Mechanistically, Cr 3ϩ reversed hyperinsulinemia-induced cellular cholesterol accrual and associated defects in cholesterol transporter ATP-binding cassette transporter-A1 trafficking and apolipoprotein A1-mediated cholesterol efflux. Moreover, direct activation of AMP-activated protein kinase, which is known to be activated by Cr 3ϩ , or inhibition of hexosamine biosynthesis pathway activity, which is known to be elevated by hyperinsulinemia, mimics Cr 3ϩ action. Conclusion-These findings suggest a mechanism of Cr 3ϩ action that fits with long-standing claims of its role in cholesterol homeostasis. Furthermore, these data imply a mechanistic basis for the coexistence of dyslipidemia with hyperinsulinemia. ) is classified as an essential micronutrient for optimal carbohydrate and lipid metabolism. Although evidence relating Cr 3ϩ deficiency and cardiovascular disease is fragmentary, deficiency has been linked to reduced high-density lipoprotein cholesterol (HDL-C). 1 A ratelimiting step in HDL-C generation entails cholesterol transporter ABCA1-mediated cholesterol efflux to lipidpoor apolipoprotein A1 (ApoA1). The HDL-C particle formed is pre-␤-1 HDL-C, a subclass that removes cholesterol from macrophages, 2 a cardioprotective event. These findings raise the question of whether an essential mechanism of Cr 3ϩ action involves ABCA1/ApoA1-mediated pre-␤-1 HDL-C generation. Importantly, ABCA1/ApoA1 dysregulation may represent an unappreciated basis of low HDL-C coexisting with metabolic derangements (eg, hyperinsulinemia).
Methods
Insulin-sensitive and hyperinsulinemia-induced insulin-resistant 3T3-L1 adipocytes and Cr 3ϩ in the picolinate form at a 1 mol/L dose were used as previously described. 3, 4 Detailed methods and information on Cr 3ϩ doses and forms tested are provided in the supplemental material, available online at http://atvb.ahajournals.org.
Results
Examination of ABCA1 trafficking revealed that plasma membrane ABCA1 was diminished by hyperinsulinemic conditions relevant to disease, 3 yet in the presence of Cr 3ϩ , this was prevented ( Figure 1A ). Endosomal membrane (EM) ABCA1 was elevated by hyperinsulinemia and normalized by Cr 3ϩ ( Figure 1B ). Total ABCA1 protein was not changed (Supplemental Figure IA) . Mechanistically, ABCA1 is regulated by the EM-to-cytosol (Cyto) cycling of the GTPase Rab8. Hyperinsulinemia increased and decreased EM-and Cyto-Rab8, respectively, and these changes were normalized by Cr 3ϩ ( Figure 1C and 1D ). Cholesterol accumulation has been implicated in EM ABCA1 sequestration in Niemann-Pick disease, type C. 5 As in NiemannPick disease, type C, a substantial increase in EM cholesterol was found in cells cultured under hyperinsulinemic conditions that Cr 3ϩ prevented (Figure 2A ). Interestingly, exercise is recognized to increase HDL-C levels, and like exercise, Cr 3ϩ increases AMP-activated protein kinase (AMPK) activity, 4 which is known to suppress cholesterol synthesis. 6 Figure 2C ) and corrected membrane Rab8/ABCA1 levels (Supplemental Figure IB to IE) ; however, a gain in Cyto-Rab8 was not seen, likely because of a shorter AICAR treatment duration not permitting a detectable level of Rab8 to accumulate in the dilute cytosol fraction. Importantly, Cr 3ϩ and AICAR both prevented hyperinsulinemia-impaired ApoA1-mediated cholesterol efflux ( Figure 2D) .
In contrast to AMPK, increased hexosamine biosynthesis pathway activity has been implicated in cholesterol accrual induced by hyperinsulinemia. 7 Testing the effect of the hexosamine biosynthesis pathway inhibitor 6-diazo-5-oxo-L-norleucine revealed Cr 3ϩ -and AICAR-like effects ( Figure 2D ). Neither agent nor Cr 3ϩ displayed any effect on control cells. Also, cholesterol lowering with methyl-␤-cyclodextrin mimicked the protective effect on ApoA1-mediated cholesterol efflux (Supplemental Figure IF) .
Discussion
The role of Cr 3ϩ in health and disease is complex. Although patients with diabetes on Cr 3ϩ supplementation see improvement in hyperglycemia, benefits on raising HDL-C remain unclear. 8 An emerging understanding is that total HDL-C measurements are misleading in understanding its cardioprotective actions, as the ABCA1-generated pre-␤-1 HDL-C particle likely represents the "functional" subfraction. 2 Therefore, study demonstrating that Cr 3ϩ enhances this ABCA1-mediated event in cells cultured in a diabetic milieu is significant.
As the serum concentration of the pre-␤-1 HDL-C accounts for only a small fraction of total HDL-C, trials designed to assess the benefits of Cr 3ϩ on total HDL-C may have had an inherent flaw in understanding Cr 3ϩ 's effect. In addition, Cr 3ϩ deficiency in humans is expected to be slight, if any 9 ; thus, measurement of a supplemental effect may be negligible. Nevertheless, analyses reveal that popular weight loss diets provide Cr 3ϩ at suboptimal levels. 10 Mechanistically, the observation that AMPK stimulation ramps up ABCA1/ApoA1 functionality is interesting, given the appreciated benefits of exercise, a known stimulant of AMPK activity, on the prevention of metabolic syndrome and its consequences. In this regard, skeletal muscle and adipose tissue contain more cholesterol than any other organ. 11 In fact, the importance of adipose tissue cholesterol in the generation of HDL-C has recently been recognized. 12, 13 In particular, the generation of pre-␤-1 HDL-C appears to be critical in mediating cholesterol efflux from cholesterol-laden macrophages. The idea that Cr 3ϩ could have an indirect effect on cholesterol handling by macrophages is of interest. Testing this possibility, as well as characterizing any direct effect that Cr 3ϩ may have on macrophage cholesterol metabolism, is warranted.
In closing, these data suggest that low circulating HDL-C, resulting from metabolic disorder, may arise from hyperinsulinemia/hexosamine biosynthesis pathway-mediated peripheral tissue cholesterol accrual ( Figure 2E ). This is associated with an EM sequestration of Rab8/ABCA1 and low pre-␤-1 HDL-C. Data also imply that Cr 3ϩ suppresses cholesterol synthesis/accrual via AMPK, and this improves Rab8/ABCA1 functionality and HDL-C generation. Whether this cell-based model explains the benefits of Cr 3ϩ or exercise in humans with diabetes remains to be validated. 
